Company
CanadaPublic company, NYSE: ABTAbbott Laboratories Co. (NYSE: ABT), Victoriaville, Canada – FDA Inspections
Inspection records and compliance data for Abbott Laboratories Co. in Victoriaville. 5 FDA inspections on record, last inspected August 08, 2025. Publicly traded as NYSE: ABT.
Company Profile
This profile covers Abbott Laboratories Co. based in Victoriaville, Canada.
FDA Inspection History
- FDA inspections
- 5
- OAI
- 0
- VAI
- 1
- NAI
- 3
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected February 16, 2009. Last inspected August 8, 2025.
FDA inspections (5)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| August 8, 2025 | Not classified | Human Drugs | 1285350 |
| August 31, 2018 | NAI | Human Drugs · Drug Quality Assurance | 1069535 |
| February 28, 2014 | NAI | Human Drugs · Drug Quality Assurance | 875184 |
| September 23, 2011 | VAI | Human Drugs · Drug Quality Assurance | 749750 |
| February 16, 2009 | NAI | Human Drugs · Drug Quality Assurance | 566440 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Other regulators (1)
- Health Canada · 2 inspections · last September 23, 2024
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Abbott Laboratories Co.
Stock ticker
ABT
Exchange
NYSE
Share price
$113.74
Market cap
$197.0B
Price as of
November 6, 2026
FEI Number
3001859812
Canada Business Number
869546291NS0006
Address
75 Pierre-Roux Blvd E, Victoriaville, Canada
Country
Canada
ID: 96ee91e5-9731-4cf6-8da2-0aec4e4ffb9b